Does UPADACITINIB Cause Myositis? 112 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 112 reports of Myositis have been filed in association with UPADACITINIB (Rinvoq). This represents 0.2% of all adverse event reports for UPADACITINIB.
112
Reports of Myositis with UPADACITINIB
0.2%
of all UPADACITINIB reports
87
Deaths
103
Hospitalizations
How Dangerous Is Myositis From UPADACITINIB?
Of the 112 reports, 87 (77.7%) resulted in death, 103 (92.0%) required hospitalization, and 88 (78.6%) were considered life-threatening.
Is Myositis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UPADACITINIB. However, 112 reports have been filed with the FAERS database.
What Other Side Effects Does UPADACITINIB Cause?
Pain (4,444)
Arthralgia (3,815)
Drug ineffective (3,384)
Covid-19 (2,978)
Rheumatoid arthritis (2,730)
Pain in extremity (2,353)
Fatigue (2,153)
Fall (2,081)
Surgery (2,037)
Therapy interrupted (1,741)
What Other Drugs Cause Myositis?
NIVOLUMAB (682)
PEMBROLIZUMAB (596)
ATORVASTATIN (448)
METHOTREXATE (418)
PREDNISONE (369)
RITUXIMAB (355)
ADALIMUMAB (344)
IPILIMUMAB (305)
ATEZOLIZUMAB (249)
INFLIXIMAB (249)
Which UPADACITINIB Alternatives Have Lower Myositis Risk?
UPADACITINIB vs URAPIDIL
UPADACITINIB vs UREA
UPADACITINIB vs URIDINE TRIACETATE
UPADACITINIB vs UROFOLLITROPIN
UPADACITINIB vs URSODIOL